Summary
The product Testosterone Undecanoate 250 mg, manufactured by Olympian Pharmaceutical, underwent independent testing to verify its authenticity and potency. The sample, identified by batch number 0069, was submitted by Olympian Pharmaceutical and analyzed by Janoshik Analytical, a laboratory specializing in pharmaceutical quality control. The analysis measured the presence of Testosterone Undecanoate, with a concentration of 260.59 mg/ml, which is 4.24% above the labeled claim of 250 mg/ml.
The testing process began on 24 October 2024, with the sample received on 30 October 2024, and analysis completed on 31 October 2024. The results confirm the presence of the active ingredient, with a concentration slightly exceeding the labeled claim. Independent third-party testing remains essential to validate these findings and ensure consistency across different batches. This report serves as an educational resource to promote harm reduction and informed decision-making.
Detailed Report
Product Overview
- Manufacturer: Olympian Pharmaceutical
- Product Name: Testosterone Undecanoate 250 mg
- Active Ingredient: Testosterone Undecanoate
- Batch Number: 0069
- Expiration Date: Not provided
- Delivery Method: Injectable
Sample Acquisition and Testing
- Task Number: #51766
- Testing Ordered: 24 October 2024
- Sample Received: 30 October 2024
- Analysis Conducted By: Janoshik Analytical
- Product Submitted By: Olympian Pharmaceutical (Manufacturer)
- Analysis Paid For By: Olympian Pharmaceutical (Manufacturer)
Testing Results
- Specification: 250 mg/ml (as stated on the label)
- Measured Concentration: 260.59 mg/ml
- Accuracy: 104.24% (4.24% above the label claim)
Verification Details
Verification URL: https://janoshik.com/tests/51766_12DI8JEMC46K
Evaluation of Manufacturer-Submitted Testing
This analysis confirms that Testosterone Undecanoate 250 mg is slightly overdosed, with a measured concentration of 260.59 mg/ml. While the deviation is minimal and within an acceptable range, continued third-party verification is necessary to ensure consistent dosing across different batches. Since Olympian Pharmaceutical submitted and funded the test, independent validation remains crucial. While Janoshik Analytical is recognized for its transparent and rigorous testing protocols, additional testing across multiple samples would further confirm accuracy and reliability.
Conclusion
The analysis confirms that Testosterone Undecanoate 250 mg is slightly overdosed, with a measured concentration of 260.59 mg/ml, which is 4.24% above the labeled claim. The presence of the active ingredient is verified, with only a minor deviation in concentration. This underscores the importance of continued testing to maintain quality control and ensure product consistency. This report is provided as an educational and harm reduction resource, helping consumers make informed choices regarding testosterone-based products.
Disclaimer
This report is published for educational and harm reduction purposes. Manufacturer-submitted testing may involve inherent biases; however, it provides useful data when critically assessed alongside third-party independent results. Readers are encouraged to use this information responsibly.
